(ASND) Ascendis Pharma complete technical analysis [charts+indicators] | Buy/Sell Ascendis Pharma | (ASND) share price targets
Complete technical analysis of Ascendis Pharma (ASND) by charts plus indicators, forecast predictions and share price targets for Ascendis Pharma (ASND)
Ascendis Pharma trades in USA in Health Care sector.
Showing technical analysis as on 2026-02-18 View latest technical analysis
10 day averaged volume of Ascendis Pharma is 921900
| Date | Daily Closing Price | Open | High | Low | Volume |
| 18 Wed Feb 2026 | 226.83 | 222.55 | 228.98 | 221.67 | 0.539 times |
| 17 Tue Feb 2026 | 223.41 | 217.43 | 225.87 | 216.10 | 0.687 times |
| 13 Fri Feb 2026 | 216.32 | 217.85 | 221.79 | 213.02 | 0.758 times |
| 13 Fri Feb 2026 | 216.32 | 217.85 | 221.80 | 213.02 | 0.758 times |
| 12 Thu Feb 2026 | 218.10 | 211.00 | 222.99 | 211.00 | 1.827 times |
| 11 Wed Feb 2026 | 221.49 | 221.83 | 224.90 | 214.60 | 1.044 times |
| 10 Tue Feb 2026 | 224.19 | 221.54 | 225.19 | 213.02 | 1.049 times |
| 09 Mon Feb 2026 | 222.03 | 220.92 | 226.40 | 219.44 | 0.727 times |
| 06 Fri Feb 2026 | 222.15 | 217.73 | 223.24 | 212.70 | 0.874 times |
| 05 Thu Feb 2026 | 217.38 | 220.31 | 227.18 | 215.51 | 1.444 times |
My analysis of stock is bullish for shortterm, and stock might move up till 230.2 or till 237.3. Use a stoploss of 224.26 and if this stock hits its stoploss, then it can fall down till 218.32
Share price targets for Ascendis Pharma (ASND)
| Target Type | Value |
| Downside Target | 186.05 |
| Downside Target | 192.28 |
| Downside Target | 211.00 |
| Downside Target | 223.19 |
| Downside Target | 226.40 |
| Upside Target | 228.98 |
| Upside Target | 229.94 |
| Upside Target | 230.68 |
| Upside Target | 242.00 |
Intraday share price targets for Ascendis Pharma (ASND)
| Target Type | Value |
| Downside Intraday Target | 218.96 |
| Downside Intraday Target | 211.09 |
| Upside Intraday Target | 231.84 |
| Upside Intraday Target | 236.85 |
| Downside Intraday Target | 223.97 |
Weekly technical analysis of Ascendis Pharma (ASND)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 18 Wed Feb 2026 | 226.83 | 217.43 | 228.98 | 216.10 | 1.618 times |
| 13 Fri Feb 2026 | 216.32 | 217.85 | 221.79 | 213.02 | 0.14 times |
| 13 Fri Feb 2026 | 216.32 | 220.92 | 226.40 | 211.00 | 1.39 times |
| 06 Fri Feb 2026 | 222.15 | 225.67 | 230.68 | 212.70 | 1.438 times |
| 30 Fri Jan 2026 | 226.10 | 234.59 | 242.00 | 220.53 | 0.643 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Ascendis Pharma (ASND)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 18 Wed Feb 2026 | 226.83 | 225.67 | 230.68 | 211.00 | 0.77 times |
| 30 Fri Jan 2026 | 226.10 | 212.84 | 242.00 | 188.08 | 0.862 times |
| 31 Wed Dec 2025 | 213.41 | 210.01 | 229.94 | 192.28 | 1.473 times |
| 28 Fri Nov 2025 | 212.33 | 200.98 | 223.19 | 188.07 | 1.048 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Ascendis Pharma (ASND)
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Ascendis Pharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Ascendis Pharma in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Ascendis Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Ascendis Pharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Ascendis Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 220.26 and Ascendis Pharma (ASND) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Ascendis Pharma (ASND) stock. Volume based technical analysis of Ascendis Pharma (ASND) stock is negative.
Ascendis Pharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Ascendis Pharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Ascendis Pharma in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Ascendis Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Ascendis Pharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Ascendis Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 220.26 and Ascendis Pharma (ASND) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Ascendis Pharma (ASND) stock. Volume based technical analysis of Ascendis Pharma (ASND) stock is negative.
Ascendis Pharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.